Evolve Private Wealth’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
8,276
+570
+7% +$84.6K 0.1% 193
2026
Q1
$717K Buy
7,706
+677
+10% +$60K 0.04% 431
2025
Q4
$565K Buy
+7,029
New +$589K 0.03% 486

Other funds holding ACLS

Evolve Private Wealth's ACLS Position: Q2 2026 in Review

Evolve Private Wealth increased its Axcelis (ACLS) stake by 7.4% in Q2 2026, buying an estimated $84.6K and bringing the position to 8,276 shares worth $1.57M. The position accounts for 0.1% of the portfolio, ranked #193.

Evolve Private Wealth first reported a position in ACLS in Q4 2025 and has held it in 3 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Evolve Private Wealth held 8,276 shares of Axcelis worth $1.57M as of Q2 2026.
  • Evolve Private Wealth bought 570 Axcelis shares in Q2 2026, an estimated $84.6K.
  • Axcelis made up 0.1% of Evolve Private Wealth's portfolio in Q2 2026, its #193 holding.
  • Evolve Private Wealth first reported a position in Axcelis in Q4 2025 and has held it in 3 quarters since.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.